Market Place
Sourcing Support
Change in Number of Shares and Votes in Ascelia Pharma AB
30 Apr 2026 //
PHARMIWEB
Orviglance NDA Submitted To FDA, Pdufa Date Set For July 2026
09 Apr 2026 //
PHARMIWEB
Notice of Annual General Meeting in Ascelia Pharma AB
30 Mar 2026 //
PHARMIWEB
Ascelia Pharma To Present Orviglance Data At ESGAR 2026
27 Mar 2026 //
PHARMIWEB
Full Year & Q4 Report 2025: FDA Accepts Orviglance NDA for Review
05 Feb 2026 //
PHARMIWEB
Nomination Committee Appointed For AGM 2026 In Ascelia Pharma AB
22 Dec 2025 //
PHARMIWEB
Change In Number Of Shares And Votes In Ascelia Pharma AB
28 Nov 2025 //
PHARMIWEB
Ascelia Pharma Converts Series C Shares To Ordinary Shares
19 Nov 2025 //
PHARMIWEB
Ascelia Pharma Submits Orviglance NDA To FDA For Review
15 Nov 2025 //
ACCESSWIRE
Ascelia Pharma Files New Patent Application For Orviglance
10 Nov 2025 //
PHARMIWEB
Quarterly Report Q3 2025: Orviglance NDA Submitted to FDA
05 Nov 2025 //
PHARMIWEB
Ascelia Pharma Boosts Management For Future Growth
03 Nov 2025 //
PHARMIWEB
Change In Number Of Shares And Votes In Ascelia Pharma AB
30 Sep 2025 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.